BOTHELL, Wash. (AP) _ Alder BioPharmaceuticals Inc. (ALDR) on Thursday reported a loss of $100.3 million in its first quarter.
On a per-share basis, the Bothell, Washington-based company said it had a loss of $1.99.
The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 95 cents per share.
Alder BioPharmaceuticals shares have risen nearly 3 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $21.35, a fall of 24 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ALDR at https://www.zacks.com/ap/ALDR
Keywords: Alder BioPharmaceuticals, Earnings Report